stockrow
Friday 6 November 2026
Export CV’s income statement to Excel — free account
CapsoVision, Inc.
CapsoVision, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 million, up 15.3% from fiscal 2024.
- Revenue
- +9.89%
- EPS
- +92.6%
- Free cash flow
- −84.4%
Quarter to June 2026, against a year earlier
6.36
0.16
+2.58%
Follow CV
Alert me
CapsoVision, Inc. (CV) P/E ratio
CapsoVision, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| Sep 2025 | 0.0× | — |
| 4 more quarters | Free account |
Against its own ten years
Low 0.0×
High 0.0×
Ten-year median
0.0×
Current reading's percentile
100
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| SI Shoulder Innovations, Inc. compare | n/m |
| OFIX ORTHOFIX MEDICAL INC. compare | n/m |
| MOBI Mobia Medical, Inc compare | n/m |
| CLPT ClearPoint Neuro, Inc. compare | n/m |
| CV CapsoVision, Inc. | n/m |
| RCEL Avita Medical Inc. compare | n/m |
| TMCI Treace Medical Concepts, Inc. compare | n/m |
| BWAY Brainsway Ltd. Sponsored ADR compare | 21.2× |
| VMD Viemed Healthcare, Inc. compare | 22.0× |
| Medical Devices industry median | 25.6× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)